Subodh Devabhaktuni

Associate Professor

UAMS

Last publication 2025 Last refreshed 2026-05-23

faculty

Internal Med, College of Medicine

9 h-index 40 pubs 369 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Subodh Devabhaktuni, M.D., is an Associate Professor in the Department of Internal Medicine at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He specializes in the treatment of heart rhythm disorders, including atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia, utilizing both medications and catheter ablation. Dr. Devabhaktuni also implants pacemakers and defibrillators. His clinical interests include novel physiologic pacing techniques such as conduction system pacing and leadless pacing, comprehensive care for atrial fibrillation through a multidisciplinary approach, and stroke prevention strategies in patients with atrial fibrillation.

Dr. Devabhaktuni's research has focused on areas such as conduction system pacing, with a recent publication surveying its worldwide implantation and outcomes. He has also contributed to meta-analyses on treatments for heart failure with preserved ejection fraction and on comparing electrode positions for biphasic cardioversion in atrial fibrillation. His work extends to investigating adverse cardiac events in women with non-obstructive coronary artery disease and comparing anticoagulation therapies for left ventricular thrombus.

He has authored numerous articles on these topics and serves on the editorial boards for several cardiology-focused journals, including the Journal of Clinical Cardiology and Cardiovascular Therapy. Dr. Devabhaktuni leads a research group and collaborates with several colleagues at UAMS, including Hakan Paydak, J. Paul Mounsey, Srikanth Vallurupalli, and Naga Sai Shravan Turaga.

Research Overview

Subodh Devabhaktuni, M.D., is assistant professor of medicine and associate program director of director of cardiology fellowship program at the University of Arkansas for Medical Sciences (UAMS). He graduated from Guntur Medical College in Guntur, India, and trained in cardiology at University of Nevada School of Medicine and in clinical cardiac electrophysiology at Indiana University. Dr Devabhaktuni specializes in treatment of heart rhythm disorders. He treats disorders like atrial fibrillation, supraventricular tachycardia, ventricular tachycardia with medications and catheter ablation, implants pacemakers and defibrillators. Catheter ablation is a procedure to fix abnormal heart rhythm problems in a minimally invasive way. His areas of interest include novel physiologic pacing techniques like conduction system pacing, leadless pacing, comprehensive care of atrial fibrillation with multidisciplinary approach and stroke prevention strategies in atrial fibrillation. He published several articles on these topics. He serves on the editorial boards of Journal of Clinical Cardiology and Cardiovascular Therapy, Cardiology Cases and Systematic Reviews and the Journal of Innovations in Cardiac Rhythm Management. He serves as a reviewer for multiple journals including Heart Rhythm Case Reports and the Journal of Innovations in Cardiac Rhythm Management. Dr Devabhaktuni is board certified in internal medicine, cardiovascular diseases and clinical cardiac electrophysiology. He is a fellow of the American College of Cardiology and Heart Rhythm Society.

Metrics

h-index: 9
Publications: 40
Citations: 369

Selected Publications

Contemporary Practices for Management of Subclinical Atrial Fibrillation (2025)

DOI OpenAlex
Dual-morphology Bundle Branch Re-entrant Ventricular Tachycardia in Non-dilated Cardiomyopathy (2025)

DOI OpenAlex
Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance (2024)

1 citation DOI OpenAlex
Stress and Percutaneous Coronary Intervention Outcomes – A Holistic Approach to Heart–Brain Connection (2024)

1 citation DOI OpenAlex
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024)

1 citation DOI OpenAlex
Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks—A Rare Case of Triple Counting (2023)

DOI OpenAlex
WAVELET DECOMPOSITION USING FAST FOURIER TRANSFORMFOR THE PREDICTION OF INCIDENT ATRIAL FIBRILLATION ON ELECTROCARDIOGRAPHY (2023)

DOI OpenAlex
Abstract 15427: Reduction of Epicardial Fat, Clinical Risk Factors & Symptomatology in Paroxysmal AF Patient With Severe Aortic Stenosis and Metabolic Syndrome via Mobile Cardiometabolic Health & Weight Loss Program (2022)

DOI OpenAlex
A CASE OF IDIOPATHIC HEMORRHAGIC PERICARDIAL EFFUSION: NO CLUES LEFT BEHIND (2022)

1 citation DOI OpenAlex
Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation (2022)

4 citations DOI OpenAlex
Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART (2021)

11 citations DOI OpenAlex
Direct Oral Anticoagulants Versus Warfarin in Left Ventricular Thrombus (2021)

9 citations DOI OpenAlex
Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter (2021)

4 citations DOI OpenAlex
Recurrence of complete heart block in pregnancy (2021)

4 citations DOI OpenAlex
The sensitivity of graphic trends in differentiating sinus and supraventricular tachycardia (2021)

1 citation DOI OpenAlex

View all publications on OpenAlex →

Research Interests

Areas of interest include novel physiologic pacing techniques like conduction system pacing, leadless pacing, comprehensive care of atrial fibrillation with multidisciplinary approach and stroke prevention strategies in atrial fibrillation.

Grants & Funding

Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (The RAPID Study (NODE-301 Part 2)) (IRB 262818) Milestone Pharmaceuticals - Pass Through: Medpace Clinical Research Principal Investigator
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (The RAPID Study (NODE-301 Part 2)) (IRB 262818) Milestone Pharmaceuticals - Pass Through: Medpace Clinical Research Principal Investigator